Skip to content
★ Sign in to follow
Jiangsu Apon Medical Technology Co., Ltd. logo

Jiangsu Apon Medical Technology Co., Ltd. Stock: price and insider trades · China

爱朋医疗

CN·Mcap CN¥2.4BHealth Care

No insider purchase over the last 90 days. The latest, by 朱红毅, was filed 26 Jul 2024.

Jiangsu Apon Medical Technology Co., Ltd.: what insiders have been doing

Jiangsu Apon Medical Technology Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Jiangsu Apon Medical Technology Co., Ltd. has had no insider filing for more than a year; the last one goes back to 11 August 2025.

Looking back to 2021, when coverage begins, insiders filed 1 purchase and 8 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€26,479
1 ops. · all time
Sell Volume
€6M
8 ops. · all time

Who traded when

BuySale
李庆2 sales

Since the insiders bought

  • Filed 26 Jul 2024 · 835 days ago · €26k
    +173.0%
    Entry CN¥10.78 · Close at T+365 CN¥29.43

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 19,164 of 26,911 companies
37.3
score / 100
Value
33
Quality
42
FCF yld-0.3%
Earn yld-1.0%
EV/EBITDA·
ROE-2.8%
Gross mgn68%
Net mgn-7.0%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥19.07
Analyst consensus
·
Income statement
RevenueCN¥342M
Gross profitCN¥234.1M68% margin
EBITDA-CN¥1.4M-0% margin
Net income-CN¥24M-4.4% margin
Valuation
P/Book3.7x
Beta0.52
Balance sheet & cash
Market capCN¥2.4B
Total debtCN¥118.6M
Free Cash Flow-CN¥6.1M
Debt / Equity13%
Profitability & ownership
ROE-2.8%
ROA-1.2%
% insiders41.4%
% institutions3.3%
Last declaration on 11 August 2025
Declarations9 total
  • ▼
    高管Executives
    510,474 CNY12SZSE
    14,900 shares13.1% of flowA股XSHESZSE:173000009340961340
  • ▼
    高管Executives
    3M CNY19SZSE
    89,300 shares86.9% of flowA股XSHESZSE:173000009337089820
  • ▲
    高管Executives
    207,800 CNY19SZSE
    20,000 shares100.0% of flowA股XSHESZSE:173000007890860480
    Canonical exit: 24 Oct 2024 (T+90)
  • ▼
    董事,总经理Executives
    27M CNY42SZSE
    2,410,000 shares100.0% of flowA股XSHESZSE:173000005699580300
  • ▼
    董事Executives
    243,950 CNY28SZSE
    17,000 shares60.1% of flowA股XSHESZSE:173000005658098200
  • ▼
    监事Executives
    2M CNY27SZSE
    114,576 shares100.0% of flowA股XSHESZSE:173000005602401180
  • ▼
    董事Executives
    3M CNY22SZSE
    250,000 shares29.6% of flowA股XSHESZSE:173000005602401150
  • ▼
    董事Executives
    7M CNY14SZSE
    600,000 shares70.4% of flowA股XSHESZSE:173000005584468860
  • ▼
    董事Executives
    177,918 CNY11SZSE
    7,800 shares39.9% of flowA股XSHESZSE:173000004531281400

9 of 9 declarations

About Jiangsu Apon Medical Technology Co., Ltd.

爱朋医疗 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations